Showing 24,861 - 24,880 results of 24,967 for search 'more optimization', query time: 0.29s Refine Results
  1. 24861
  2. 24862
  3. 24863
  4. 24864

    The Journey to Advanced Clinical Pharmacy Practice: Global Collaboration Will Accelerate the Pace by Paul W. Bush

    Published 2021-12-01
    “…</p><p>It was defined as the direct, responsible provision of medication-related care for the purpose of achieving definite outcomes that improve a patient’s quality of life.  In 1993, more than 200 participants met in San Antonio at the ASHP Conference on Implementing Pharmaceutical Care. …”
    Get full text
    Article
  5. 24865

    Dissecting the link between PD-1/PD-L1-based immunotherapy and cancer pain: mechanisms, research implications, and artificial intelligence perspectives by Marco Cascella, Brigida Miranda, Carmen Gagliardi, Lucia Santaniello, Milena Mottola, Alida Mancusi, Laura Ferrara, Federica Monaco, Francesca Gargano, Francesco Perri, Alessandro Ottaiano, Maurizio Capuozzo, Ornella Piazza, Stefano Pepe, Anna Crispo, Agostino Guida, Giovanni Salzano, Giustino Varrassi, Luigi Liguori, Francesco Sabbatino, The TRIAL Group

    Published 2024-12-01
    “…Cancer-related pain represents one of the most common complaints of cancer patients especially for those with advanced-stage of disease and/or bone metastases. More effective therapeutic strategies are needed not only to improve the survival of cancer patients but also to relieve cancer-related pain. …”
    Get full text
    Article
  6. 24866
  7. 24867

    Comprehensive analysis of culture-negative periprosthetic joint infection with metagenomic next-generation sequencing by Lan Lin, Lan Lin, Lan Lin, Jiayu Li, Jiayu Li, Jiayu Li, Canhong Zhang, Juncheng Li, Juncheng Li, Juncheng Li, Baijian Wu, Baijian Wu, Baijian Wu, Zida Huang, Zida Huang, Zida Huang, Jianhua Lv, Mingzhong Liu, Wenbo Li, Wenbo Li, Wenbo Li, Wenming Zhang, Wenming Zhang, Wenming Zhang, Xinyu Fang, Xinyu Fang, Xinyu Fang

    Published 2025-05-01
    “…With advancements in sample collection, optimized culture methods, molecular diagnostic tools, and early targeted therapies, CN PJI may achieve clinical outcomes comparable to CP PJI.…”
    Get full text
    Article
  8. 24868
  9. 24869
  10. 24870
  11. 24871

    Real-world practices of low-molecular-weight heparin for venous thromboembolism prophylaxis in patients hospitalized with COVID-19: a multicenter prospective study from China by Feiya Xu, Yuzhi Tao, Lijun Chen, Yunhui Zhang, Binliang Wang, Jing Han, Chaosheng Deng, Weijia Liu, Guohui Fan, Rui Liang, Zhaofei Chen, Yinong Chen, Kaiyuan Zhen, Yunxia Zhang, Zhu Zhang, Shuai Zhang, Jun Wan, Wanmu Xie, Peiran Yang, YuTing Kang, Dingyi Wang, Chen Wang, Zhenguo Zhai

    Published 2025-06-01
    “…Despite guidelines recommending prophylactic anticoagulation, particularly for those in intensive care, real-world adherence and optimal venous thromboembolism (VTE) prevention strategies remain challenging, particularly in populations with complex comorbidities. …”
    Get full text
    Article
  12. 24872
  13. 24873

    Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study by K. Mancuso, R. Mina, S. Rocchi, E. Antonioli, M. T. Petrucci, F. Fazio, A. Gozzetti, M. Salvini, C. S. Cartia, G. Bertuglia, F. Patriarca, A. B. Dalla Palma, S. Barbato, G. De Cicco, F. Bigi, E. Favero, P. Tacchetti, L. Pantani, I. Rizzello, M. Puppi, M. Talarico, V. Solli, A. Kanapari, M. Cavo, E. Zamagni

    Published 2024-11-01
    “…ABSTRACT Introduction MGRS are new rare clinical entities, whose recognition and optimal management is evolving. Methods To implement real‐life data, we retrospectively analysed a multicentre cohort of 60 patients with renal biopsy‐proven MGRS receiving mainly novel treatments (between 2006 and 2021) in eight Italian centres. …”
    Get full text
    Article
  14. 24874
  15. 24875

    Balancing the benefits and risks of colchicine use among patients with atherosclerotic cardiovascular disease: an umbrella review of meta-analyses of randomised controlled trialsRe... by Rui-Han Bao, Na Zhao, Xiao-Feng Jiang, Zi-Han Cong, Jun Liu, Long-Dan Kang, Yu-Han Chen, Jia-Nan Sun, Wei-Yi Xing, Jia-Xin Liu, Xue-Li Bai, Hai-Chen Lv, Jing-Ying Zhao, Qi-Peng Ma, Ting-Ting Gong, Qi-Jun Wu

    Published 2025-06-01
    “…Subgroup analyses indicated that optimal clinical application required consideration of patient age, geographic variance in pharmacogenomics, and protocol adjustments (recommended dose ≤0.5 mg/day for more than a month) to balance efficacy–risk profiles. …”
    Get full text
    Article
  16. 24876
  17. 24877
  18. 24878

    Unveiling neurogenic biomarkers for the differentiation between sepsis patients with or without encephalopathy: an updated meta-analysis by Jiyun Hu, Wenchao Li, Shucai Xie, Ya Liao, Tao Chen, Xinrun Wang, Weiping Xia, Fang Huang, Zhaoxin Qian, Lina Zhang

    Published 2025-02-01
    “…Accurate diagnosis of SAE is crucial for the timely initiation of optimal treatment and appropriate patient management. …”
    Get full text
    Article
  19. 24879
  20. 24880